Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Patent
1997-03-12
1999-02-02
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
424473, A61K 942
Patent
active
058661646
ABSTRACT:
A composition of matter is disclosed and claimed comprising an opioid antagonist and a high molecular weight poly(alkylene) or a poly(carboxymethylcellulose). A dosage form is disclosed and claimed comprising the composition of matter for displacing an opioid analgesic from the dosage form.
REFERENCES:
patent: 3845770 (1974-11-01), Theeuwes et al.
patent: 3916899 (1975-11-01), Theeuwes et al.
patent: 4008719 (1977-02-01), Theeuwes et al.
patent: 4036228 (1977-07-01), Theeuwes
patent: 4111201 (1978-09-01), Theeuwes
patent: 4111202 (1978-09-01), Theeuwes
patent: 4327725 (1982-05-01), Cortese et al.
patent: 4519801 (1985-05-01), Edgren
patent: 4576604 (1986-03-01), Guittard et al.
patent: 4612008 (1986-09-01), Wong et al.
patent: 4844907 (1989-07-01), Elger et al.
patent: 5021053 (1991-06-01), Barclay et al.
patent: 5198229 (1993-03-01), Wong et al.
patent: 5312389 (1994-05-01), Theeuwes et al.
patent: 5326571 (1994-07-01), Wright et al.
patent: 5460826 (1995-10-01), Merill et al.
patent: 5529787 (1996-06-01), Merrill et al.
Zenz et al., Chemical Abstracts, vol. 122, #142620, 1994.
Barclay Glen E.
Childers Jerry D.
Kuczynski Anthony L.
Merrill Sonya
Rodriguez Susan
ALZA Corporation
Page Thurman K.
Rafa Michael J.
Sabatine Paul
Shelborne Kathryne E.
LandOfFree
Composition and dosage form comprising opioid antagonist does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition and dosage form comprising opioid antagonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and dosage form comprising opioid antagonist will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1114822